The Libertines' Pete Doherty has been told he's at risk of losing his toes after being diagnosed with type 2 diabetes - but the star has admitted to 'lacking discipline' ...

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

Rocker Pete Doherty has opened up about his health after doctors warned he risks facing an amputation after his health ...

The Libertines singer, 45, who was diagnosed with the chronic disease last year, has performed from a chair on the last five ...

The GLP-1 medication trend has taken the health and wellness world by storm, largely hailed as a game-changer for weight loss ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

FOX 2 - A 100-year-old vaccine is getting a fresh look as it's being studied to treat an autoimmune disease. One local child who's hoping to help change the world for people with type 1 diabetes.

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...